Managing Agitated Delirium With Neuroleptics and Anti-Epileptics as a Neuroleptic Sparing Strategy
Status:
Not yet recruiting
Trial end date:
2025-08-01
Target enrollment:
Participant gender:
Summary
To examine the effects of haloperidol, chlorpromazine, valproic acid and placebo, in
conjunction with standardized non-pharmacologic interventions, in the first line treatment of
agitated delirium in hospitalized patients with cancer. This double-blind, randomized
clinical trial aims to provide evidence on various therapeutic options for palliating
delirium, thereby reducing delirium-related distress and ultimately alleviating suffering.